Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TEVA NEUROSCIENCE, INC.

Home Clinical Trial Sponsors and OrganizationsTEVA NEUROSCIENCE, INC.

TEVA NEUROSCIENCE, INC.

CLOSED

17795 W 106TH St, 密苏里州杰克逊县, 密苏里州, United StatesPrivate

Also known as:

teva neuroscience

Part of Teva Pharmaceutical Industries Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

10

0 active

Approvals

6

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

5

50.0%

Phase 3

2

20.0%

Phase 1

1

10.0%

Trial Status Distribution

Completed

10

100.0%

Clinical Trials

Trials sponsored by this organization (10)

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Jul 2010148 participants

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Dec 2009328 participants

Therapy Optimization in Multiple Sclerosis (MS)

Dec 20082,878 participants

A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

Apr 200760 participants

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Oct 2006200 participants

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

Jan 2006307 participants

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Aug 200550 participants

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Aug 200450 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

6

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials10
Approvals6
News

Back to Organizations